Leishmania (V.) guyanensis: Isolation and characterization of glucantime-resistant cell lines

Canadian Journal of Microbiology

Volumn 42, Issue 9, 1996, Pages 944-949

  Ferreira Pinto, K C ^a   Miranda Vilela, A L ^a   Anacleto, C ^a   Fernandes, A P S M ^a   Abdo, M C B ^a   Petrillo Peixoto, M L ^a   Moreira, E S A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Gene amplification; Glucantime resistance; Leishmania; Pentavalent antimony

Indexed keywords

ANTIMONY; HEAVY METAL; MEGLUMINE ANTIMONATE; PUROMYCIN; STIBOGLUCONATE SODIUM; VINBLASTINE;

ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; GENE AMPLIFICATION; LEISHMANIA; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; LEISHMANIA GUYANENSIS; LEISHMANIA TARENTOLAE;

EID: 0029905794     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/m96-121     Document Type: Article

References (33)

1. Beverley, S.M. 1991. Gene amplification in Leishmania. Annu. Rev. Microbiol. 45: 417-444.
2. Beverley, S.M., Coderre, J.A., Santi, D.V., and Schimke, R.T. 1984. Unstable DNA amplification in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Cell, 38: 431-439.
3. Borst, P., and Ouellette, M. 1995. New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49: 427-460.
4. Callahan, H.L. and Beverley, S.M. 1991. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J. Biol. Chem. 266(26): 18424-18430.
5. Callahan, H.L., and Beverley, S.M. 1992. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania. J. Biol. Chem. 267(34): 24165-24168.
6. Chin, K.V., Tanaka, S., Darlington, G., Pastan, I., and Gottesman, M.M. 1990. Heat shock and arsenate increase expression of the multidrug resistance (mdr 1) gene in human carcinoma cells. J. Biol. Chem. 265: 221-226.
7. Church, G.M., and Gilbert, W. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. U.S.A. 81(7): 1991-1995.
8. Dey, S., Papadopoulou, B., Haimeur, A., Roy, G., Grondin, K., Dou, D., Rosen, B.P., and Ouellette, M. 1994. High level of arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol. Biochem. Parasitol. 67: 49-57.
9. Ellenberger, T.E., and Beverley, S.M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. J. Biol. Chem. 264: 15094-15103.
10. Feinberg, A.P., and Vogelstein, B. 1983. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266-267.
11. Figueiredo, Y., Costa, C.A., Mayrink, W., Araujo, F.C., Dias, M., Melo, M.N., Magalhães, P., Willians, P., Batista, S.M., and Coelho, M.V. 1976. Nutrição e metabolismo de formas de cultura de Leishmania. Rev. Inst. Med. Trop. Sao Paulo, 18: 306-314.
12. Grogl, M., Rodger, K.M., Oduala, A.M.J., Milhous, W.K., and Kyle, D.E. 1991. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components. J. Trop. Med. Hyg. 45(1): 98-111.
13. Grogl, M., Thomason, T.N., and Franke, E.D. 1992. Drug resistance in Leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47(1): 117-126.
14. Grondin, K., Papadopoulou, B., and Ouellette, M. 1993. Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res. 21(8): 1895-1901.
15. Hightower, R.C., Ruiz-Perez, L.M., Wong, M.L., and Santi, D.V. 1988. Extrachromossomal elements in the lower eukaryote Leishmania. J. Biol. Chem. 263(32): 16970-16976.
16. 50 in studies of drug resistance of malaria parasites. Acta Trop. 55: 257-261.
17. Jackson, J.E., Tally, J.D., Ellis, W.Y., Mebralitu, Y.B., Lawyer, P.G., Were, J.B., Reed, S.G., Panisko, D.M., and Limmer, B.L. 1990. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp from patients unresponsive to pentavalent antimony therapy. Am. J. Trop. Med. Hyg. 43: 464-480.
18. Lara, J. 1992. Localização de sequências funcionais em DNA circular e amplificado de Leishmania tarentolae. Ms thesis, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.
19. Légaré, D., Hettema, E., and Ouellette, M. 1994. The P-glycoprotein-related gene family in Leishmania. Mol. Biochem. Parasitol. 68: 81-91.
20. Moreira, E.S.A., and Petrillo-Peixoto, M.L. 1991. In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes. Braz. J. Med. Biol. Res. 24: 459-469.
21. Moreira, E.S.A., Guerra, J.B., and Petrillo-Peixoto, M.L. 1992. Glucantime resistant Leishmania promastigotes are sensitive to pentostam. Rev. Soc. Bras. Med. Trop. 25: 247-250.
22. Moreira, E.S.A., Soares, R.M.A., and Petrillo-Peixoto, M.L. 1995. Glucantime susceptibility of Leishmania promastigotes under variable growth conditions. Parasitol. Res. 81(4): 291-295.
23. Ouellette, M., and Borst, P. 1991. Drug resistance and P-glycoprotein gene amplification in the protozoa parasite Leishmania. Res. Microbiol. 142: 737-746.
24. Ouellette, M., Fase-Fowler, F., and Borst, P. 1990. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9(4): 1027-1033.
25. Ouellette, M., Hettema, E., Wust, D., Fase-Fowler, F., and Borst, P. 1991. Direct and inverted repeats associated with P-glycoprotein gene amplification in drug resistance Leishmania. Embo J. 10: 1009-1016.
26. Papadopoulou, B., Roy, G., and Ouellette, M. 1992. A novel antifolate resistance gene of the amplified H circle of Leishmania. EMBO J. 11(10): 3601-3608.
27. Papadopoulou, B., Roy, G., and Ouellette, M. 1993. Frequent amplification of a short chain dehydrogenase gene as part of circular and linear amplicons in methotrexate resistant Leishmania. Nucleic Acids Res. 21: 4305-4312.
28. Papadopoulou, B., Roy, G., Dey, S., Rosen, B.P., and Ouellette, M. 1994. Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance. J. Biol. Chem. 269: 11980-11986.
29. Petrillo-Peixoto, M.L., and Beverley, S.M. 1988. Amplified DNAs in laboratory stocks of Leishmania tarentolae: extrachromossomal circles structurally and functionally similar to the inverted H region amplification of methotrexate-resistant L. major. Mol. Cell. Biol. 8: 5188-5199.
30. Roberts, W.L., and Rainey, D.M. 1993. Antileishmanial activity of sodium stibogluconate fractions. Antimicrob. Agents Chemother. 37: 1842-1846.
31. Southern, E. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503.
32. Ullman, B., Carrero-Valenzuela, E., and Coons, T. 1989. Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines. Exp. Parasitol. 69: 157-163.
33. White, T.C., Fase-Fowler, F., van Luene, H., Calafat, J., and Borst, P. 1988. The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance. J. Biol. Chem. 263: 16977-16983.